Adverse Event Reporting
| VAERS ID | 1464906 |
|---|---|
| Gender | Female |
| Age | |
| StateCode | FR |
| Pharmaceutical Company | PFIZER\BIONTECH |
| Lot Number | |
| Number of vaccinations | 1 |
| Vaccinated | 2021-06-01 |
| Onset | 2021-06-14 |
| Condition |
Symptoms
- Dyspnoea
- Migraine
- Metamorphopsia
- Menstruation irregular
- Somatic symptom disorder of pregnancy
Current Illness
Preexisting Conditions
Medical History/Concurrent Conditions: Asthma; Disorder gastrointestinal; Glaucoma; Lactation decreased
Other Medications
Previous Vaccinations
Allergies
Laboratory Data
Write-up
False pregnancy; Irregular periods; Difficulty breathing; Distorted vision; Migraine NOS; This is a spontaneous report from a contactable consumer or other non hcp received from the Regulatory Authority.
The regulatory authority report number is GB-MHRA-WEBCOVID-202106242211312540-TZC50.
Safety Report Unique Identifier GB-MHRA-ADR 25539284.
A 29-year-old female non patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number and expiry date: not reported) via an unspecified route of administration on 01Jun2021 as single dose for COVID-19 immunisation.
Medical history included gastrointestinal disorder, suppressed lactation, glaucoma, asthma.
Patient has not had symptoms associated with COVID-19 and not had a COVID-19 test.
Patient is not enrolled in clinical trial.
Patient is not currently breastfeeding.
Patient has not tested positive for COVID-19 since having the vaccine.
The patient's concomitant medications were not reported.
On 14Jun2021, the patient experienced false pregnancy, irregular periods, difficulty breathing, distorted vision, migraine nos.
The events were reported as serious, medically significant.
Pregnancy tests have come back positive and negative on and off with no usual period and no unprotected sexual activity.
The outcome of the events was reported as not recovered.
No follow-up attempts are possible; Information about lot/batch number cannot be obtained.